Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim

被引：0
|
作者：
Tomonori Nakazato
Chisako Ito
Ai Mihara
Yoshinobu Aisa
机构：
[1] Yokohama Municipal Citizen’s Hospital,Department of Hematology
来源：
International Journal of Hematology | 2013年 / 97卷
关键词：
Platelet Count; Danazol; Romiplostim; Eltrombopag; Immune Thrombocytopenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：291 / 293
页数：2
相关论文
共 50 条
  • [1] Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim
    Nakazato, Tomonori
    Ito, Chisako
    Mihara, Ai
    Aisa, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 291 - 293
  • [2] The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim
    Al-Samkari, Hanny
    Schifferli, Alexandra
    Gonzalez-Lopez, Tomas J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1143 - 1145
  • [3] Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
    Nam, Chang Hyun
    Byun, Ja Min
    Shin, Dong-Yeop
    Hong, Junshik
    Kim, Inho
    Yoon, Sung-Soo
    Koh, Youngil
    BLOOD RESEARCH, 2021, 56 (03) : 202 - 204
  • [4] Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
    Bidika, Erjola
    Fayyaz, Hafsa
    Salib, Marina
    Memon, Areeba N.
    Gowda, Asavari S.
    Rallabhandi, Bhavana
    Cancarevic, Ivan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [5] Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    BLOOD, 2018, 132
  • [6] Cost-minimization analysis of immune thrombocytopenia treatment with romiplostim and eltrombopag
    Marzal Alfaro, M. B.
    Marquinez Alonso, I.
    Escudero Vilaplana, V.
    Pernia Lopez, S.
    Sanjurjo Saez, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 975 - 976
  • [7] Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1501 - 1508
  • [8] Diagnosis of venous thromboembolism during eltrombopag therapy for immune thrombocytopenia and successful replacement with romiplostim
    Amit, O.
    Kirgner, I
    Avivi, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 606 - 607
  • [9] ROMIPLOSTIM AND ELTROMBOPAG FOR IMMUNE THROMBOCYTOPENIA: METHODS FOR INDIRECT COMPARISON
    Cooper, Katy L.
    Fitzgerald, Patrick
    Dillingham, Kerry
    Helme, Kawitha
    Akehurst, Ron
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (03) : 249 - 258
  • [10] Romiplostim as early treatment for refractory primary immune thrombocytopenia
    Contis, Anne
    Lazaro, Estibaliz
    Greib, Carine
    Pellegrin, Jean-Luc
    Viallard, Jean-Francois
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (05) : 520 - 524
12345